The King and Queen of Sweden are touring AstraZeneca’s Discovery Center on a visit to Cambridge
The King and Queen of Sweden visited AstraZeneca’s new Discovery Center today (Thursday), where they heard about the technology the company uses to develop new therapies.
King Carl XVI Gustaf and Queen Silvia visited the £ 1 billion R&D site on the Cambridge Biomedical Campus, known as DISC, which was officially opened in November by Prince Charles.
The visit was hosted by the board of the British-Swedish company Leif Johansson and Sir Mene Pangalos, executive vice president, biopharmaceuticals R&D.
Sir Mene told Cambridge Independent: “We had the honor of welcoming King Carl XVI Gustaf and Queen Silvia of Sweden to our Discovery Center, together with the Swedish Minister of Education and Research, together with delegates from her ministry, the Swedish Embassy and Business Sweden.
“It was a privilege to show the King and Queen our groundbreaking science, including organ chips, advanced integrated imaging, advanced lab technology and cellular heartbeats.
“They also heard from colleagues who played a crucial role in the Covid-19 pandemic, including how we developed the vaccine and our preventive antibody therapy, Evusheld.”
As part of their visit to Cambridge, the King and Queen also hosted Professor Stephen Toope, Vice-Chancellor of the University of Cambridge, at King’s College for a celebration of Anglo-Swedish scientific collaboration.
Read more
Prince Charles visits AstraZeneca to unveil Discovery Center, its £ 1bn R&D site in Cambridge
Sir Mene Pangalos among Cambridge-based scholars selected as new fellows in the Royal Society